These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 17112324

  • 1. Oral combination therapy with thiazolidinediones in type 2 diabetes.
    LaSalle JR, Cross LB.
    Am J Manag Care; 2006 Nov; 12(14 Suppl):S369-81. PubMed ID: 17112324
    [Abstract] [Full Text] [Related]

  • 2. Metformin and pioglitazone: Effectively treating insulin resistance.
    Staels B.
    Curr Med Res Opin; 2006 Nov; 22 Suppl 2():S27-37. PubMed ID: 16914073
    [Abstract] [Full Text] [Related]

  • 3. [Triple oral therapy in type 2 diabetes].
    Scheen AJ.
    Rev Med Suisse; 2005 Aug 24; 1(30):1942, 1944-6, 1948. PubMed ID: 16200937
    [Abstract] [Full Text] [Related]

  • 4. Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration.
    Kahler KH, Rajan M, Rhoads GG, Safford MM, Demissie K, Lu SE, Pogach LM.
    Diabetes Care; 2007 Jul 24; 30(7):1689-93. PubMed ID: 17440170
    [Abstract] [Full Text] [Related]

  • 5. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M, Lam S.
    Cardiol Rev; 2007 Jul 24; 15(5):264-71. PubMed ID: 17700385
    [Abstract] [Full Text] [Related]

  • 6. Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes.
    Raskin P.
    Diabetes Metab Res Rev; 2008 Jul 24; 24(1):3-13. PubMed ID: 17968971
    [Abstract] [Full Text] [Related]

  • 7. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
    Aquilante CL, Zhang W, McCollum M.
    Curr Med Res Opin; 2007 Mar 24; 23(3):489-94. PubMed ID: 17355730
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies.
    Penfornis A, Borot S, Raccah D.
    Diabetes Metab; 2008 Feb 24; 34 Suppl 2():S78-90. PubMed ID: 18640590
    [Abstract] [Full Text] [Related]

  • 9. [2-year data of large clinical comparative studies. Type 2 diabetes: lasting metabolic control with pioglitazone].
    MMW Fortschr Med; 2004 Jul 22; 146(29-30):48-9. PubMed ID: 15540563
    [No Abstract] [Full Text] [Related]

  • 10. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA, Kane MP, Busch RS.
    Pharmacotherapy; 2007 Oct 22; 27(10):1449-55. PubMed ID: 17896900
    [Abstract] [Full Text] [Related]

  • 11. Update on type 2 diabetes mellitus: understanding changes in the diabetes treatment paradigm.
    Green J, Feinglos M.
    Int J Clin Pract Suppl; 2007 Aug 22; (154):3-11. PubMed ID: 17593272
    [Abstract] [Full Text] [Related]

  • 12. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M, Orsini-Federici M.
    Diabetes Care; 2008 Feb 22; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [Abstract] [Full Text] [Related]

  • 13. Consulting on the patient with type 2 diabetes: matching medication to disease mechanism.
    Manag Care; 2007 Jun 22; 16(6 Suppl 5):2-11. PubMed ID: 17703795
    [Abstract] [Full Text] [Related]

  • 14. Initiating insulin in patients with type 2 diabetes.
    Aoki TJ, White RD.
    J Fam Pract; 2007 Aug 22; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139
    [Abstract] [Full Text] [Related]

  • 15. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P.
    Diabetes Obes Metab; 2008 Dec 22; 10(12):1167-77. PubMed ID: 18494804
    [Abstract] [Full Text] [Related]

  • 16. The importance of beta-cell management in type 2 diabetes.
    Standl E.
    Int J Clin Pract Suppl; 2007 Jun 22; (153):10-9. PubMed ID: 17594389
    [Abstract] [Full Text] [Related]

  • 17. Balancing risk and benefit with oral hypoglycemic drugs.
    Hamnvik OP, McMahon GT.
    Mt Sinai J Med; 2009 Jun 22; 76(3):234-43. PubMed ID: 19421967
    [Abstract] [Full Text] [Related]

  • 18. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions.
    Dagogo-Jack S, Santiago JV.
    Arch Intern Med; 1997 Sep 08; 157(16):1802-17. PubMed ID: 9290539
    [Abstract] [Full Text] [Related]

  • 19. Pioglitazone and sulfonylureas: effectively treating type 2 diabetes.
    Hanefeld M.
    Int J Clin Pract Suppl; 2007 Jun 08; 61(153):20-7. PubMed ID: 17594390
    [Abstract] [Full Text] [Related]

  • 20. [Therapy with oral antidiabetic agents -- special considerations in the case of coronary heart disease].
    Nauck MA, Matthaei S.
    Dtsch Med Wochenschr; 2005 Apr 29; 130(17):1091-6. PubMed ID: 15841424
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.